Alan M. Ezrin
Gründer bei NX Pharmagen, Inc.
Profil
Alan M.
Ezrin is the founder of NX PharmaGen, Inc. in 2010, where he currently holds the title of Chief Executive Officer & Director.
Dr. Ezrin is also the founder of Pioma, Inc., NX Development Corp...
Dr. Ezrin's former job(s) include being the President, Chief Executive Officer & Director at Bradmer Pharmaceuticals, Inc. from 2010 to 2013, Assistant Vice President-Experimental Therapeutics at Glycomed, Inc., Chief Scientific Officer at Correvio Pharma Corp.
from 2001 to 2006, Chief Scientific Officer at ConjuChem, Inc., and Vice President-PreClinical Development at Redcell Canada, Inc. from 1995 to 2010.
Aktive Positionen von Alan M. Ezrin
| Unternehmen | Position | Beginn |
|---|---|---|
NX Pharmagen, Inc.
 NX Pharmagen, Inc. BiotechnologyHealth Technology NX Pharmagen, Inc. acquires, develops, and monetizes mature clinical-stage breakthrough technologies. Its products include NeXosome Prenatal & Oncology Diagnostics and Gliolan. The company was founded by Alan M. Ezrin and Brian D. Brohman and is headquartered in Louisville, KY. | Gründer | 01.03.2010 |
Ehemalige bekannte Positionen von Alan M. Ezrin
| Unternehmen | Position | Ende |
|---|---|---|
| CORREVIO PHARMA CORP. | Technik-/Wissenschafts-/F&E-Leiter | - |
NX Development Corp.
 NX Development Corp. Medical SpecialtiesHealth Technology NX Development Corp. operates as a life science company. It develops Gleolan oral solutions which helps in identifying malignant glioma, a type of brain tumor in adult patients. It allows surgeons to visualize brain tumors during surgery. The company was founded by Alan Ezrin and is headquartered in Lexington, KY. | Vorstandsvorsitzender | - |
Pioma, Inc.
 Pioma, Inc. Industrial SpecialtiesProcess Industries Pioma, Inc. manufactures chemicals for textiles. The private company is based in Miami. The American company was founded by Alan M. Ezrin. | Gründer | - |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Technik-/Wissenschafts-/F&E-Leiter | - |
Redcell Canada, Inc.
 Redcell Canada, Inc. Electrical ProductsProducer Manufacturing Part of Infobooth, Inc., Redcell Canada, Inc. markets and distributes quality portable power batteries. The company is based in Vancouver, Canada. Redcell Canada was acquired by Infobooth, Inc. on May 23, 2002. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
Bradmer Pharmaceuticals, Inc.
 Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
NX Pharmagen, Inc.
NX Pharmagen, Inc. BiotechnologyHealth Technology NX Pharmagen, Inc. acquires, develops, and monetizes mature clinical-stage breakthrough technologies. Its products include NeXosome Prenatal & Oncology Diagnostics and Gliolan. The company was founded by Alan M. Ezrin and Brian D. Brohman and is headquartered in Louisville, KY. | Health Technology |
NX Development Corp.
NX Development Corp. Medical SpecialtiesHealth Technology NX Development Corp. operates as a life science company. It develops Gleolan oral solutions which helps in identifying malignant glioma, a type of brain tumor in adult patients. It allows surgeons to visualize brain tumors during surgery. The company was founded by Alan Ezrin and is headquartered in Lexington, KY. | Health Technology |
Redcell Canada, Inc.
Redcell Canada, Inc. Electrical ProductsProducer Manufacturing Part of Infobooth, Inc., Redcell Canada, Inc. markets and distributes quality portable power batteries. The company is based in Vancouver, Canada. Redcell Canada was acquired by Infobooth, Inc. on May 23, 2002. | Producer Manufacturing |
Pioma, Inc.
Pioma, Inc. Industrial SpecialtiesProcess Industries Pioma, Inc. manufactures chemicals for textiles. The private company is based in Miami. The American company was founded by Alan M. Ezrin. | Process Industries |
